title: Place of preoperative treatment of acromegaly with somatostatin analog on surgical outcome: a systematic review and meta-analysis.
abstract: BACKGROUND
  Transsphenoidal neurosurgery is the accepted first-line treatment of acromegaly in the majority of patients. Previous studies addressing preoperative somatostatin analog (SSA) treatment and subsequent surgical cure rates are conflicting, reporting either benefits or no significant differences.
  
  
  OBJECTIVE
  The aim of this study, based on a meta-analysis of all published reports, was to investigate whether treatment with SSA before surgery improves the surgical outcome of acromegaly.
  
  
  METHODS
  All studies of preoperative treatment of acromegaly with SSA were systematically reviewed up to December 2011. We searched the Medline, Embase, Cochrane and Google Scholar electronic databases.
  
  
  METHODS
  The primary endpoint was the biochemical postoperative cure rate. We identified 286 studies, out of which 10 studies (3.49%) fulfilling the eligibility criteria were selected for analysis; five retrospective studies with a control group, two prospective non-randomized trials, and three prospective controlled trials. The meta-analysis was conducted using the random-effects model.
  
  
  METHODS
  Data were extracted from published reports by two independent observers.
  
  
  RESULTS
  A borderline effect was detected in the analysis of all of the trials with control groups, with a pooled odds ratio (OR) for biochemical cure with SSA treatment of 1.62 (95% CI, 0.93-2.82). In the analysis of the three prospective controlled trials, a statistically significant effect was identified OR: 3.62 (95% CI, 1.88-6.96).
  
  
  CONCLUSIONS
  Preoperative treatment with SSA og GH-secreting pituitary adenomas shows a significant improvement on surgical results. This meta-analysis suggests that in centers without optimal results all patients with a GH-secreting pituitary macroadenoma should be treated with a long-acting SSA prior to surgical treatment.
authors: Department of Endocrinology, University Hospital A Coruña, A Coruña, Spain.
authors: Francisco
authors: F
authors: Pita-Gutierrez
authors: Sonia
authors: S
authors: Pertega-Diaz
authors: Salvador
authors: S
authors: Pita-Fernandez
authors: Lara
authors: L
authors: Pena
authors: Gloria
authors: G
authors: Lugo
authors: Susana
authors: S
authors: Sangiao-Alvarellos
authors: Fernando
authors: F
authors: Cordido
mesh_terms: D000172:Acromegaly / Q000188:drug therapy* / Q000601:surgery*; D006801:Humans; D007902:Length of Stay; D011300:Preoperative Care / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D013004:Somatostatin
references: J Clin Endocrinol Metab. 2011 May;96(5):1327-35
references: 21325455
references: Neurol Neurochir Pol. 2001 Mar-Apr;35(3):423-37
references: 11732266
references: Acta Endocrinol (Copenh). 1987 Feb;114(2):249-56
references: 2881419
references: Neurosurg Clin N Am. 2003 Jan;14(1):25-39, vi
references: 12690977
references: J Clin Endocrinol Metab. 2008 Aug;93(8):2984-90
references: 18492760
references: Clin Endocrinol (Oxf). 2003 Apr;58(4):387-99
references: 12641619
references: Pituitary. 1999 Jun;2(1):29-41
references: 11081170
references: Clin Endocrinol (Oxf). 2012 Mar;76(3):399-406
references: 21824170
references: J Clin Endocrinol Metab. 1988 Nov;67(5):1040-8
references: 2903168
references: Eur J Endocrinol. 2005 Mar;152(3):379-87
references: 15757854
references: Metabolism. 1996 Aug;45(8 Suppl 1):72-4
references: 8769388
references: J Clin Endocrinol Metab. 2009 May;94(5):1509-17
references: 19208732
references: J Clin Endocrinol Metab. 1994 Nov;79(5):1416-23
references: 7962337
references: J Clin Endocrinol Metab. 1999 Oct;84(10):3551-5
references: 10522994
references: J Clin Endocrinol Metab. 2012 Aug;97(8):E1411-20
references: 22659247
references: Acta Neurochir (Wien). 2005 May;147(5):485-93; discussion 493
references: 15806331
references: Annu Rev Pathol. 2009;4:97-126
references: 19400692
references: Horm Metab Res. 2011 Jul;43(8):580-6
references: 21667426
references: Endocr Pract. 2011 Jul-Aug;17 Suppl 4:1-44
references: 21846616
references: Endocr Rev. 2004 Feb;25(1):102-52
references: 14769829
references: Eur J Endocrinol. 2005 Dec;153(6):737-40
references: 16322377
references: J Clin Invest. 2009 Nov;119(11):3189-202
references: 19884662
references: J Neurosurg. 2006 Jun;104(6):899-906
references: 16776333
references: Clin Endocrinol (Oxf). 2011 Jun;74(6):736-43
references: 21521254
references: Endocr Rev. 2011 Apr;32(2):247-71
references: 21123741
references: Acta Neurochir (Wien). 1999;141(4):399-405
references: 10352750
references: Eur J Endocrinol. 2010 Oct;163(4):609-16
references: 20616109
references: J Neurosurg. 1994 Jul;81(1):10-4
references: 8207509
references: J Clin Endocrinol Metab. 1997 Oct;82(10):3308-14
references: 9329359
references: Mol Cell Endocrinol. 2011 Mar 30;335(2):177-88
references: 21241769
references: J Clin Endocrinol Metab. 2005 Jul;90(7):4405-10
references: 15827109
references: Eur J Endocrinol. 2010 Apr;162(4):661-6
references: 20061334
references: Endocr Rev. 2003 Feb;24(1):28-47
references: 12588807
references: Eur J Endocrinol. 2001 Aug;145(2):137-45
references: 11454508
references: Clin Endocrinol (Oxf). 1998 Nov;49(5):653-7
references: 10197082
references: PLoS One. 2012;7(5):e36411
references: 22574156
references: Clin Endocrinol (Oxf). 2008 Jun;68(6):970-5
references: 18031313
references: Neurol Med Chir (Tokyo). 1999 Jul;39(7):496-9; discussion 499-501
references: 10437377
references: J Clin Endocrinol Metab. 2010 Sep;95(9):4114-23
references: 20823464
references: J Clin Endocrinol Metab. 2008 Aug;93(8):2975-7
references: 18685119
references: Endocr J. 2010;57(12):1035-44
references: 21099129
references: Clin Endocrinol (Oxf). 2003 Apr;58(4):471-81
references: 12641631
references: Eur J Endocrinol. 2007 Oct;157(4):399-409
references: 17893253
references: J Clin Endocrinol Metab. 2006 Jan;91(1):85-92
references: 16263832
references: J Clin Endocrinol Metab. 2011 Sep;96(9):2732-40
references: 21715544
references: Growth Horm IGF Res. 2003 Aug;13 Suppl A:S144-51
references: 12914744
references: Chin Med Sci J. 2005 Mar;20(1):23-6
references: 15844307
references: Endocr J. 1998 Apr;45(2):269-75
references: 9700482
references: Endocr J. 2006 Feb;53(1):125-32
references: 16543682